Caterina Gasperini

Caterina Gasperini

Auto-generated profile, based on publicly available information

Caterina Gasperini

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Stem Cell Reports
Verified
Journal Article
Open access
MPMeritxell Pons-Espinal
Meritxell Pons-Espinal
CGCaterina Gasperini
Caterina Gasperini
MMMatteo Jacopo Marzi
Matteo Jacopo Marzi
CBClarissa Braccia
Clarissa Braccia
AAAndrea Armirotti
Andrea Armirotti
DTDavide De Pietri Tonelli
Davide De Pietri Tonelli
Physical exercise stimulates adult hippocampal neurogenesis and is considered a relevant strategy for preventing age-related cognitive decline in humans. The underlying mechanisms remains controversial. Here, we show that exercise increases proliferation of neural precursor cells (NPCs) of the mouse dentate gyrus (DG) via downregulation of microRNA 135a-5p (miR-135a). MiR-135a inhibition stimulates NPC proliferation leading to increased neurogenesis, but not astrogliogenesis, in DG of resting mice, and intriguingly it re-activates NPC proliferation in aged mice. We identify 17 proteins (11 putative targets) modulated by miR-135 in NPCs. Of note, inositol 1,4,5-trisphosphate (IP3) receptor 1 and inositol polyphosphate-4-phosphatase type I are among the modulated proteins, suggesting that IP3 signaling may act downstream miR-135. miR-135 is the first noncoding RNA essential modulator of the brain's response to physical exercise. Prospectively, the miR-135-IP3 axis might represent a novel target of therapeutic intervention to prevent pathological brain aging.

6 December 2022 in EMBO Reports
Verified
Journal Article
Open access
CGCaterina Gasperini
Caterina Gasperini
KTKiril Tuntevski
Kiril Tuntevski
SBSilvia Beatini
Silvia Beatini
RPRoberta Pelizzoli
Roberta Pelizzoli
AVAmanda Lo Van
Amanda Lo Van
DTDavide De Pietri Tonelli
Davide De Pietri Tonelli
Adult neural progenitor cells (aNPCs) ensure lifelong neurogenesis in the mammalian hippocampus. Proper regulation of aNPC fate has thus important implications for brain plasticity and healthy aging. Piwi proteins and the small noncoding RNAs interacting with them (piRNAs) have been proposed to control memory and anxiety, but the mechanism remains elusive. Here, we show that Piwil2 (Mili) is essential for proper neurogenesis in the postnatal mouse hippocampus. RNA sequencing of aNPCs and their differentiated progeny reveal that Mili and piRNAs are dynamically expressed in neurogenesis. Depletion of Mili and piRNAs in the adult hippocampus impairs aNPC differentiation toward a neural fate, induces senescence, and generates reactive glia. Transcripts modulated upon Mili depletion bear sequences complementary or homologous to piRNAs and include repetitive elements and mRNAs encoding essential proteins for proper neurogenesis. Our results provide evidence of a critical role for Mili in maintaining fitness and proper fate of aNPCs, underpinning a possible involvement of the piRNA pathway in brain plasticity and successful aging.

19 June 2015 in Toxics
Verified
Journal Article
Open access
PDF file
GBGraziella Bernocchi
Graziella Bernocchi
Francesco Paolo FanizziFrancesco Paolo Fanizzi
Francesco Paolo Fanizzi
SPSandra A. De Pascali
Sandra A. De Pascali
VPValeria M. Piccolini
Valeria M. Piccolini
CGCaterina Gasperini
Caterina Gasperini
Maria Grazia BottoneMaria Grazia Bottone
Maria Grazia Bottone
Platinum compounds cause significant clinical neurotoxicity. Several studies highlight neurological complications especially in paediatric oncology patients with Central Nervous System (CNS) and non-CNS malignancies. To understand the toxicity mechanisms of platinum drugs at cellular and molecular levels in the immature brain, which appears more vulnerable to injury than in the adult one, we compared the effects in vivo of the most used platinum compounds, i.e., cisdichlorodiammineplatinum (cisplatin, cisPt), and the new [Pt(O,O′-acac)(γ-acac)(DMS)] (PtAcacDMS). As models of developing brain areas, we have chosen the cerebellum and hippocampus dentate gyrus. Both areas show the neurogenesis events, from proliferation to differentiation and synaptogenesis, and therefore allow comparing the action of platinum compounds with DNA and non-DNA targets. Here, we focused on the changes in the intracellular calcium homeostasis within CNS architecture, using two immunohistochemical markers, the calcium buffer protein Calbindin and Plasma Membrane Calcium ATPase. From the comparison of the cisPt and PtAcacDMS effects, it emerges how essential the equilibrium and synergy between CB and PMCA1 is or how important the presence of at least one of them is to warrant the morphology and function of nervous tissue and limit neuroarchitecture damages, depending on the peculiar and intrinsic properties of the developing CNS areas.

27 June 2019 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
VIVioletta Insolia
Violetta Insolia
Erica Cecilia PrioriErica Cecilia Priori
Erica Cecilia Priori
CGCaterina Gasperini
Caterina Gasperini
FCFederica Coppa
Federica Coppa
MCMarco Cocchia
Marco Cocchia
Maria Grazia BottoneMaria Grazia Bottone
Maria Grazia Bottone

15 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CGC. Gasperini
C. Gasperini
KTK. Tuntevski
K. Tuntevski
RPR. Pelizzoli
R. Pelizzoli
AVA. Lo Van
A. Lo Van
DMD. Mangoni
D. Mangoni
DTD De Pietri Tonelli
D De Pietri Tonelli
In specific niches of the adult mammalian brain, neural progenitor cells (aNPCs) ensure lifelong neurogenesis. Proper regulation of this process entails important implications for brain plasticity and health. We report that Piwil2 (Mili) and PIWI-interacting RNAs (piRNAs) are abundantly expressed in aNPCs but depleted in their progeny in the adult mouse hippocampus. Loss of function of the piRNA pathway in aNPCs inhibited neurogenesis and increased reactive gliogenesis in vivo and in vitro. PiRNA pathway depletion in cultured aNPCs increased levels of 5S ribosomal RNA, transfer RNAs and mRNAs encoding regulators of translation, resulting in higher polyribosome density and protein synthesis upon differentiation. We propose that the piRNA pathway sustains adult neurogenesis by repressing translation in aNPCs. One sentence summary The piRNA pathway is enriched in neural precursors and essential for appropriate neurogenesis by modulating translation

1 April 2025 in Stroke
Verified
Journal Article
Closed access
OCOri S. Cohen
Ori S. Cohen
MSManisha Sinha
Manisha Sinha
YWYongting Wang
Yongting Wang
TDTyler Daman
Tyler Daman
PLPi-Chun Li
Pi-Chun Li
ASAnthony Sandrasagra
Anthony Sandrasagra
BACKGROUND: Stroke remains a leading cause of death and disability, underscoring the urgent need for treatments that enhance recovery. GDF11 (growth differentiation factor 11), a member of the TGF-β (transforming growth factor-β) superfamily, is a circulating protein involved in cellular development and tissue repair. GDF11 has gained attention for its potential regenerative properties in aging and disease contexts, making it a candidate for stroke recovery therapies. METHODS: The therapeutic benefits of rGDF11 (recombinant GDF11) were evaluated using a rat ischemic stroke model, in which focal cerebral infarcts were induced in 8- to 10-week-old young adult male Sprague-Dawley rats by permanently occluding the proximal right middle cerebral artery. Rats received single or multiple doses of rGDF11 (0.1–4 mg/kg) or vehicle from 24 to 72 hours post-injury. Sensorimotor functions were evaluated, and brain and serum samples were examined to determine the mechanisms of action and identify biomarkers, using immunofluorescence, target-specific ELISAs, and an aptamer-based proteomics platform. RESULTS: We confirmed rGDF11 activity in vitro and in established in vivo mouse models of cardiac hypertrophy and glucose metabolism and assessed the efficacy of rGDF11 treatment in 6 preclinical stroke studies using independent Contract Research Organizations, with all study animals and treatment groups blinded. All 6 studies revealed consistent improvement in sensorimotor outcomes with rGDF11. rGDF11-treated rats showed increased cortical vascularization and radial glia in the ventricular zone. Serum analysis revealed that rGDF11 caused dose-dependent decreases in CRP (C-reactive protein) and identified novel pharmacodynamic biomarkers and pathways associated with potential mechanisms of action of rGDF11. CONCLUSIONS: These results demonstrate that systemically delivered rGDF11 enhances neovascularization, reduces inflammation, promotes neurogenesis, and improves sensorimotor function post-injury in a rat model of ischemic stroke. More importantly, these data define an optimized and clinically feasible rGDF11 dosing regimen for therapeutic development in ischemic stroke and identify a panel of candidate pharmacodynamic and mechanistic biomarkers to support clinical translation.